Skip to main navigation Skip to search Skip to main content

Coagulation factor XIII serves as protein disulfide isomerase

  • Judith Lahav
  • , Eli Karniel
  • , Zsuzsa Bagoly
  • , Vera Sheptovitsky
  • , Rima Dardik
  • , Aida Inbal*
  • *Corresponding author for this work
  • Rabin Medical Center Israel
  • Meir Hospital Sapir Medical Center
  • University of Debrecen
  • Sheba Medical Center at Tel Hashomer

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

Tissue transglutaminase was reported to act as protein disulfide isomerase (PDI). We studied whether plasma transglutaminase - coagulation factor XIII (FXIII) - has PDI activity as well. PDI activity was measured by determining the ability to renature reduced-denatured RNase (rdRNase). We found that FXIII can renature rdRNase, with efficiency comparable to commercial PDI. This PDI activity was inhibited by bacitracin. Like tissue transglu-taminase, FXIII-mediated PDI activity is independent of its transglutaminase activity and is located on the A subunit. Surface-associated PDI has been previously shown to catalyse two distinct functions: transnitrosation with subsequent release of intracellular nitric oxide and disulfide bond rearrangement during platelet integrin ligation. Our results imply that FXIII-PDI activity may have a role in platelet function.

Original languageEnglish
Pages (from-to)840-844
Number of pages5
JournalThrombosis and Haemostasis
Volume101
Issue number5
DOIs
StatePublished - May 2009

Keywords

  • Factor XIII
  • PDI
  • Transglutaminase

Fingerprint

Dive into the research topics of 'Coagulation factor XIII serves as protein disulfide isomerase'. Together they form a unique fingerprint.

Cite this